2025–2026 research library
Digital Health Research
Current market intelligence, funding analysis, ecosystem reports, and strategic briefings.
Health Management Solutions: Health Revolution Congress 2026
Presented by Galen Growth at Health Revolution Congress 2026 in Barcelona, this presentation explores how Health Management Solutions are becoming the operating layer of modern healthcare as AI adoption, investment and enterprise-scale deployment accelerate.
Exits Are Back. Easy Exits Aren't.
M&A now accounts for 95% of digital health exits as the IPO window stays shut to all but the most evidence-led ventures. Galen Growth's Digital Health Exits 2026 report — powered by HealthTech Alpha — analyses 282 exits from 2025 to June 2026 and the Roche/PathAI deal that turns vendor neutrality into a board-level governance question.
Global Digital Health Funding and Key Trends 2025: Re-priced, Re-proved, Re-focused
In 2025, capital snapped back only for real performers—ventures proving adoption, unit economics, and execution. Health systems tightened the rules, demanding workflow fit and ROI. Evidence, interoperability, and distribution now separate contenders from pretenders as the market reopens, raising the stakes for anyone who can’t deliver measurable value.
The Power Players: The Top Investors Shaping Digital Health in Europe and Beyond
Discover the 2025 rankings of the top 50 investors shaping Digital Health in Europe, North America, and APAC. Powered by 2 billion data points, this report reveals the "Power Players" driving innovation in TechBio, Femtech, and Clinical Trials.
Pharmaceutical Digital Health Innovation Index, 5th Edition
Digital health is no longer a side experiment—it’s reshaping how pharma discovers, develops, and delivers therapies. As companies race to build evidence-driven partnerships and real digital impact, the gap between leaders and followers is widening. Galen Growth’s 5th annual Pharmaceutical Digital Health Innovation Index reveals who is truly executing, who isn’t, and what it takes to stay ahead in an industry transforming at unprecedented speed—right now globally today.
Clearing the Bottleneck: How Digital Innovation is Driving Clinical Trials
Clinical trials—the backbone of drug development—are finally being rewritten by digital innovation. From AI-driven design to decentralised, patient-centric models, technology is slashing timelines, cutting costs, and widening access. Yet funding for these ventures has plunged 46% in five years, just as demand for faster, smarter R&D reaches record highs. This report unpacks how startups, investors, and pharma can seize the opportunity to turn the industry’s biggest bottleneck into its most powerful accelerator.
Europe Q2 Digital Health 2025 Funding and Key Trends: Breaking the Mold
In the ever-evolving landscape of Digital Health, Europe has emerged as a formidable leader, breaking the mould and setting new benchmarks for innovation and growth. This report delves into the remarkable achievements of the European Digital Health sector in the first half of 2025, highlighting how the region has outperformed other global regions in funding, partnerships, and technological advancements.
United States Q2 Digital Health 2025 - Funding and Key Trends Navigating Toward Health Impact
Digital Health isn’t declining—it’s sharpening. The first half of 2025 showed global Digital Health evolving beyond the hype, entering a phase where results matter more than buzz. The US share of global funding reached a five-year low, with other regions accelerating their growth over the first half of the year. Investors are being selective, focusing on clinically validated solutions that streamline care and prove profitability.
APAC Digital Health H1 2025 – Rising with AI Transformation
The first half of 2025 underscores APAC’s pivotal role in digital health, with the region securing $1.2B across 102 deals (4% YoY growth) despite a global 11% decline. APAC now represents 9% of total global funding, led by Australia ($286M), Hong Kong ($233M), and Japan ($202M). Investments are increasingly directed towards AI-powered diagnostics, remote patient monitoring, and precision medicine, signaling the region’s transition from hype to measurable health impact. Globally, $12.6B was invested across 616 deals, but APAC’s funding resilience and AI-driven innovation highlight its growing influence on the digital health landscape.
Q2 2025 Digital Health Funding: From Hype to Health Impact
Digital health is growing up. In Q2 2025, the sector shifted gears—from inflated promises to evidence-driven results. With $12.1B invested globally, mature ventures offering clinical validation and cost savings took centre stage. Europe outpaced expectations, AI proved its staying power, and partnerships slowed under rising scrutiny. This is not decline—it is discipline. The winners now are those who deliver real-world health impact with precision, efficiency, and purpose.
Femtech’s Challenge: Growth, Gaps, and the Health Equity Imperative
What if half the population’s health needs were an afterthought in global innovation—and what if fixing that presented a hundred-billion-dollar opportunity? Femtech is no longer just about fertility apps; it’s redefining how healthcare serves women across every stage of life. This report dives deep into the data behind the momentum, the money, and the massive market gaps that innovators and investors can no longer afford to ignore.
The Green Promise of Digital Health
The Green Promise of Digital Health dives into how digital technologies like telemedicine, remote monitoring, and AI can cut healthcare’s carbon footprint and transform care. It urges strategic use to ensure these tools benefit both people and the planet.
European Digital Health: Q1 2025 Investment Trends Report
The European Digital Health: Investment Surges in Q1 2025 report delivers a comprehensive analysis of the latest funding trends, ecosystem dynamics, and innovation hotspots shaping the digital health landscape across Europe. In Q1 2025, the region witnessed a remarkable $2.1 billion in funding—its second-highest quarterly total—accounting for 32% of global digital health investment. Over 3,800 ventures now operate across Europe, with the UK, Germany, and France leading in ecosystem size and funding activity.
Consumer HealthTech: A Paradigm Shift in Healthcare
The healthcare industry is undergoing a profound transformation, driven by the rapid rise of Consumer HealthTech—digital healthcare technology innovations that empower individuals to take control of their health. This shift is not only redefining patient engagement but also reshaping the healthcare ecosystem by increasing accessibility, personalisation, and efficiency.
Digital Health 2024 Funding and Key Trends: Resilience, Recovery, and the Road Ahead
The Global Digital Health Ecosystem Report for FY 2024 captures a year defined by transformation, resilience and recovery. Following a period of uncertainty, the digital health sector demonstrated renewed vigour, achieving a modest yet significant recovery in global funding, totalling $25.1 billion—a 5.5% increase year over year. This growth highlights the sector’s ability to adapt and innovate amidst lingering challenges.